GSK-3 Inhibitors: Anti-Diabetic Treatment Associated with Cardiac Risk?
Crossref DOI link: https://doi.org/10.1007/s10557-016-6669-y
Published Online: 2016-06-16
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nabben, Miranda
Neumann, Dietbert
Funding for this research was provided by:
NWO-ZonMw (916.14.050)
NWO-ALW (864.10.007)
License valid from 2016-06-01